Ann: VIRALEZE relaunched by LloydsPharmacy in the UK, page-73

the whole of oncology has radical changes in the past 10 years and jacky is crazy if think old chemo drugs have the value of 5-10 years ago. Immunooncology and CAR-T


I raised this same issue the other day (below in 2 posts) about another aussie biotech that released its phase 2 results the other day - not a word from the fan club about it though... new treatments are surfacing all the time and we are still waiting on the basic DEP Docetaxel results - it's been almost 10 years since DEP Docetaxel started trials?



https://hotcopper.com.au/threads/its-the-happy-sarge-show.6810945/#post-62219125

..... as a comparison, I note today another ASX biotech is already releasing the results of their phase 2 trial after starting this trial in 2019 ..... funny how that particular company didn't use COVID-19 as an excuse for delays like this mob did and guess what, reduced toxicity plays a big part in their treatment - sound familiar ? Looks like Starpharma has been left at the starting gate ?



https://hotcopper.com.au/threads/it....6810945/page-9?post_id=62219125#.YsO6pXZBzIU


Always happy for management to prove me wrong !!